Wolverine Trading’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$232K Buy
+45,500
New +$201K ﹤0.01% 4741
2025
Q2
Sell
-13,900
Closed -$38.9K 4804
2025
Q1
$38.9K Sell
13,900
-18,600
-57% -$66.7K ﹤0.01% 4475
2024
Q4
$142K Buy
+32,500
New +$124K ﹤0.01% 4680
2024
Q1
Sell
-16,100
Closed -$56.8K 4518
2023
Q4
$56.8K Buy
16,100
+5,200
+48% +$14.9K ﹤0.01% 4226
2023
Q3
$28.2K Buy
+10,900
New +$38.3K ﹤0.01% 4279
2023
Q1
Sell
-34,000
Closed -$122K 4234
2022
Q4
$122K Sell
34,000
-3,800
-10% -$16.2K ﹤0.01% 3349
2022
Q3
$153K Sell
37,800
-10,400
-22% -$53.4K ﹤0.01% 3745
2022
Q2
$213K Buy
48,200
+9,000
+23% +$65K ﹤0.01% 3470
2022
Q1
$336K Buy
+39,200
New +$275K ﹤0.01% 3750
2021
Q4
Sell
-77,200
Closed -$796K 5893
2021
Q3
$796K Buy
+77,200
New +$674K ﹤0.01% 3301
2021
Q2
Sell
-81,600
Closed -$862K 6009
2021
Q1
$862K Buy
+81,600
New +$1.14M ﹤0.01% 2950

Other funds holding SRTA

Wolverine Trading's SRTA Position: Q1 2025 in Review

Wolverine Trading sold out of Strata Critical Medical Inc (SRTA) in Q1 2025, closing a stake of 54,045 shares — an estimated $194K sold.

Wolverine Trading first reported a position in SRTA in Q2 2023 and held it in 4 quarters. The position peaked at $237K in Q4 2024. 118 funds tracked by Wall St. Rank hold SRTA as of Q1 2025.

  • Wolverine Trading reported no remaining Strata Critical Medical Inc position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 54,045 Strata Critical Medical Inc shares in Q1 2025, an estimated $194K.
  • Wolverine Trading first reported a position in Strata Critical Medical Inc in Q2 2023 and held it in 4 quarters.
  • Wolverine Trading's Strata Critical Medical Inc position peaked at $237K in Q4 2024.
  • 118 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.